Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study

Abstract Oral lichen planus (OLP) is a common, chronic relapsing inflammatory disorder of the mucous membranes, which causes major discomfort. Current treatment includes topical/systemic glucocorticoids, immune modulators and systemic immunosuppressants, which may lead to considerable side-effects....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Raluca Cosgarea, Robert Pollmann, Jusra Sharif, Thomas Schmidt, Ronja Stein, Aura Bodea, Thorsten Auschill, Anton Sculean, Rüdiger Eming, Brandon Greene, Michael Hertl, Nicole Arweiler
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/345a7b4913854b3fb77a11804ebac6cf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:345a7b4913854b3fb77a11804ebac6cf
record_format dspace
spelling oai:doaj.org-article:345a7b4913854b3fb77a11804ebac6cf2021-12-02T14:06:51ZPhotodynamic therapy in oral lichen planus: A prospective case-controlled pilot study10.1038/s41598-020-58548-92045-2322https://doaj.org/article/345a7b4913854b3fb77a11804ebac6cf2020-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-58548-9https://doaj.org/toc/2045-2322Abstract Oral lichen planus (OLP) is a common, chronic relapsing inflammatory disorder of the mucous membranes, which causes major discomfort. Current treatment includes topical/systemic glucocorticoids, immune modulators and systemic immunosuppressants, which may lead to considerable side-effects. The aim of this study was to determine the clinical and immunological efficacy of photodynamic therapy (PDT) in OLP as an alternative, easy-to-use, safe and non-invasive treatment. Twenty patients with OLP were treated with PDT in a prospective case-controlled pilot-study. PDT was performed on the most extensive oral lesion in 4 sessions (day 1, 3, 7, 14). Peripheral blood and lesional T cells were analysed before (day 1) and after PDT treatment (day 28). PDT led to a statistically significant reduction of clinical parameters (lesion size, ABSIS, Thongprasom-score) and improvement of all evaluated quality-of-life (QOL) items. The clinical improvement was accompanied by a significant decrease of the relative number of CD4+ and CD8+ T cells in mucosal OLP-lesions. Furthermore, CXCL10 plasma levels were decreased and the number of activated peripheral CD4 + CD137+ and CD8 + CD137+ T cells and IL-17-secreting T cells was diminished. PDT treatment in OLP leads to lesion reduction and improvement of QOL, and induces local and systemic anti-inflammatory effects. The study identifies PDT as a novel therapeutic option in OLP.Raluca CosgareaRobert PollmannJusra SharifThomas SchmidtRonja SteinAura BodeaThorsten AuschillAnton SculeanRüdiger EmingBrandon GreeneMichael HertlNicole ArweilerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Raluca Cosgarea
Robert Pollmann
Jusra Sharif
Thomas Schmidt
Ronja Stein
Aura Bodea
Thorsten Auschill
Anton Sculean
Rüdiger Eming
Brandon Greene
Michael Hertl
Nicole Arweiler
Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study
description Abstract Oral lichen planus (OLP) is a common, chronic relapsing inflammatory disorder of the mucous membranes, which causes major discomfort. Current treatment includes topical/systemic glucocorticoids, immune modulators and systemic immunosuppressants, which may lead to considerable side-effects. The aim of this study was to determine the clinical and immunological efficacy of photodynamic therapy (PDT) in OLP as an alternative, easy-to-use, safe and non-invasive treatment. Twenty patients with OLP were treated with PDT in a prospective case-controlled pilot-study. PDT was performed on the most extensive oral lesion in 4 sessions (day 1, 3, 7, 14). Peripheral blood and lesional T cells were analysed before (day 1) and after PDT treatment (day 28). PDT led to a statistically significant reduction of clinical parameters (lesion size, ABSIS, Thongprasom-score) and improvement of all evaluated quality-of-life (QOL) items. The clinical improvement was accompanied by a significant decrease of the relative number of CD4+ and CD8+ T cells in mucosal OLP-lesions. Furthermore, CXCL10 plasma levels were decreased and the number of activated peripheral CD4 + CD137+ and CD8 + CD137+ T cells and IL-17-secreting T cells was diminished. PDT treatment in OLP leads to lesion reduction and improvement of QOL, and induces local and systemic anti-inflammatory effects. The study identifies PDT as a novel therapeutic option in OLP.
format article
author Raluca Cosgarea
Robert Pollmann
Jusra Sharif
Thomas Schmidt
Ronja Stein
Aura Bodea
Thorsten Auschill
Anton Sculean
Rüdiger Eming
Brandon Greene
Michael Hertl
Nicole Arweiler
author_facet Raluca Cosgarea
Robert Pollmann
Jusra Sharif
Thomas Schmidt
Ronja Stein
Aura Bodea
Thorsten Auschill
Anton Sculean
Rüdiger Eming
Brandon Greene
Michael Hertl
Nicole Arweiler
author_sort Raluca Cosgarea
title Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study
title_short Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study
title_full Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study
title_fullStr Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study
title_full_unstemmed Photodynamic therapy in oral lichen planus: A prospective case-controlled pilot study
title_sort photodynamic therapy in oral lichen planus: a prospective case-controlled pilot study
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/345a7b4913854b3fb77a11804ebac6cf
work_keys_str_mv AT ralucacosgarea photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy
AT robertpollmann photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy
AT jusrasharif photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy
AT thomasschmidt photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy
AT ronjastein photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy
AT aurabodea photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy
AT thorstenauschill photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy
AT antonsculean photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy
AT rudigereming photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy
AT brandongreene photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy
AT michaelhertl photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy
AT nicolearweiler photodynamictherapyinorallichenplanusaprospectivecasecontrolledpilotstudy
_version_ 1718391954202427392